182
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Bone turnover alterations across the menopausal transition in south-eastern Chinese women

, , , , , & show all
Pages 400-405 | Received 17 Jan 2016, Accepted 16 Apr 2016, Published online: 05 May 2016

References

  • Si L, Winzenberg TM, Chen M, Jiang Q, Palmer AJ. Residual lifetime and 10-year absolute risks of osteoporotic fractures in Chinese men and women. Curr Med Res Opin 2015;31:1149–56
  • Pinheiro MM, Ciconelli RM, Martini LA, Ferraz MB. Clinical risk factors for osteoporotic fractures in Brazilian women and men: the Brazilian Osteoporosis Study (BRAZOS). Osteoporos Int 2009;20:399–408
  • Kanis JA, McCloskey EV, Johansson H, et al. A reference standard for the description of osteoporosis. Bone 2008;42:467–75
  • Brown JP, Albert C, Nassar BA, et al. Bone turnover markers in the management of postmenopausal osteoporosis. Clin Biochem 2009;42:929–42
  • Chopin F, Biver E, Funck-Brentano T, et al. Prognostic interest of bone turnover markers in the management of postmenopausal osteoporosis. Joint Bone Spine 2012;79:26–31
  • Jiajue R, Jiang Y, Wang O, et al. Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus. Osteoporos Int 2014;25:1999–2005
  • Gordan GS. Estrogen and postmenopausal osteoporosis. Ann Intern Med 1993;118:155–6
  • Riggs BL, Khosla S, Melton LJ 3rd. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002;23:279–302
  • Greendale GA, Sowers M, Han W, et al. Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women's Health Across the Nation (SWAN). J Bone Miner Res 2012;27:111–18
  • Sun L, Peng Y, Sharrow AC, et al. FSH directly regulates bone mass. Cell 2006;125:247–260
  • Devleta B, Adem B, Senada S. Hypergonadotropic amenorrhea and bone density: new approach to an old problem. J Bone Miner Metab 2004;22:360–4
  • Crandall CJ, Tseng CH, Karlamangla AS, et al. Serum sex steroid levels and longitudinal changes in bone density in relation to the final menstrual period. J Clin Endocrinol Metab 2013;98:E654–63
  • Sowers MR, Jannausch M, McConnell D, et al. Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinol Metab 2006;91:1261–7
  • Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop+ 10: addressing the unfinished agenda of staging reproductive aging. Climacteric 2012;15:105–14
  • Komulainen M, Kroger H, Tuppurainen MT, et al. Identification of early postmenopausal women with no bone response to HRT: Results of a five-year clinical trial. Osteoporos Int 2000;11:211–18
  • Zaidi M, Blair HC, Iqbal J, et al. New insights: elevated follicle-stimulating hormone and bone loss during the menopausal transition. Curr Rheumatol Rep 2009;11:191–5
  • Podfigurna-Stopa A, Pludowski P, Jaworski M, et al. Skeletal status and body composition in young women with functional hypothalamic amenorrhea. Gynecol Endocrinol 2012;28:299–304
  • Sowers MR, Greendale GA, Bondarenko I, et al. Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN. Osteoporos Int 2003;14:191–7
  • Papakitsou EF, Margioris AN, Dretakis KE, et al. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women. Maturitas 2004;47:185–93
  • Xu ZR, Wang AH, Wu XP, et al. Relationship of age-related concentrations of serum FSH and LH with bone mineral density, prevalence of osteoporosis in native Chinese women. Clin Chim Acta 2009;400:8–13
  • Wu XY, Wu XP, Xie H, et al. Age-related changes in biochemical markers of bone turnover and gonadotropin levels and their relationship among Chinese adult women. Osteoporos Int 2010;21:275–85
  • Cheung E, Tsang S, Bow C, et al. Bone loss during menopausal transition among southern Chinese women. Maturitas 2011;69:50–6
  • Albright F, Smith PH, Richardson AM. Postmenopausal osteoporosis – its clinical features. J Am Med Assoc 1941;116:2465–74
  • Randolph JF, Sowers M, Bondarenko IV, et al. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J Clin Endocrinol Metab 2004;89:1555–61
  • Perrien DS, Achenbach SJ, Bledsoe SE. Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone. J Clin Endocrinol Metab 2006;91:1848–54
  • Garcia-Martin A, Reyes-Garcia R, Garcia-Castro JM, et al. Role of serum FSH measurement on bone resorption in postmenopausal women. Endocrine 2012;41:302–8
  • Desai MP, Bhanuprakash KV, Khatkhatay MI, et al. Age-related changes in bone turnover markers and ovarian hormones in premenopausal and postmenopausal Indian women. J Clin Lab Anal 2007;21:55–60
  • Gass ML, Kagan R, Kohles JD, et al. Bone turnover marker profile in relation to the menstrual cycle of premenopausal healthy women. Menopause 2008;15:667–75
  • Huang AJ, Ettinger B, Vittinghoff E, et al. Endogenous estrogen levels and the effects of ultra-low-dose transdermal estradiol therapy on bone turnover and BMD in postmenopausal women. J Bone Miner Res 2007;22:1791–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.